Global Duchenne Muscular Dystrophy Market Analysis 2016-2020 and Forecast 2021-2026
SNAPSHOT
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Duchenne Muscular Dystrophy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Deflazacort
- Prednisone
- Others
- PTC Therapeutics
- Sarepta Therapeutics
- Bristol-Myers Squibb
- ITALFARMACO
- BioMarin
- Daiichi Sankyo
- Solid Biosciences
- Summit Therapeutics
- FibroGen
- NS Pharma
- Pfizer
- ReveraGen BioPharma
- Wave Life
- Genethon
- Santhera Pharmaceuticals
- Male
- Female
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
- Asia-Pacific (China, India, Japan, Southeast Asia etc.)
- South America (Brazil, Argentina etc.)
- Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW
1.1 Duchenne Muscular Dystrophy Industry
Figure Duchenne Muscular Dystrophy Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Duchenne Muscular Dystrophy
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Duchenne Muscular Dystrophy
1.2.2 Downstream
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 DUCHENNE MUSCULAR DYSTROPHY MARKET BY TYPE
3.1 By Type
3.1.1 Deflazacort
Table Major Company List of Deflazacort
3.1.2 Prednisone
Table Major Company List of Prednisone
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 PTC Therapeutics (Company Profile, Sales Data etc.)
4.1.1 PTC Therapeutics Profile
Table PTC Therapeutics Overview List
4.1.2 PTC Therapeutics Products & Services
4.1.3 PTC Therapeutics Business Operation Conditions
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
4.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
4.2.2 Sarepta Therapeutics Products & Services
4.2.3 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.3.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.3.2 Bristol-Myers Squibb Products & Services
4.3.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 ITALFARMACO (Company Profile, Sales Data etc.)
4.4.1 ITALFARMACO Profile
Table ITALFARMACO Overview List
4.4.2 ITALFARMACO Products & Services
4.4.3 ITALFARMACO Business Operation Conditions
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 BioMarin (Company Profile, Sales Data etc.)
4.5.1 BioMarin Profile
Table BioMarin Overview List
4.5.2 BioMarin Products & Services
4.5.3 BioMarin Business Operation Conditions
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.6.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.6.2 Daiichi Sankyo Products & Services
4.6.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Solid Biosciences (Company Profile, Sales Data etc.)
4.7.1 Solid Biosciences Profile
Table Solid Biosciences Overview List
4.7.2 Solid Biosciences Products & Services
4.7.3 Solid Biosciences Business Operation Conditions
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
4.8.1 Summit Therapeutics Profile
Table Summit Therapeutics Overview List
4.8.2 Summit Therapeutics Products & Services
4.8.3 Summit Therapeutics Business Operation Conditions
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 FibroGen (Company Profile, Sales Data etc.)
4.9.1 FibroGen Profile
Table FibroGen Overview List
4.9.2 FibroGen Products & Services
4.9.3 FibroGen Business Operation Conditions
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 NS Pharma (Company Profile, Sales Data etc.)
4.10.1 NS Pharma Profile
Table NS Pharma Overview List
4.10.2 NS Pharma Products & Services
4.10.3 NS Pharma Business Operation Conditions
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Pfizer (Company Profile, Sales Data etc.)
4.11.1 Pfizer Profile
Table Pfizer Overview List
4.11.2 Pfizer Products & Services
4.11.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
4.12.1 ReveraGen BioPharma Profile
Table ReveraGen BioPharma Overview List
4.12.2 ReveraGen BioPharma Products & Services
4.12.3 ReveraGen BioPharma Business Operation Conditions
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
4.13 Wave Life (Company Profile, Sales Data etc.)
4.13.1 Wave Life Profile
Table Wave Life Overview List
4.13.2 Wave Life Products & Services
4.13.3 Wave Life Business Operation Conditions
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Genethon (Company Profile, Sales Data etc.)
4.14.1 Genethon Profile
Table Genethon Overview List
4.14.2 Genethon Products & Services
4.14.3 Genethon Business Operation Conditions
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Overview List
4.15.2 Santhera Pharmaceuticals Products & Services
4.15.3 Santhera Pharmaceuticals Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Male
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
6.1.2 Demand in Female
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
1.1 Duchenne Muscular Dystrophy Industry
Figure Duchenne Muscular Dystrophy Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Duchenne Muscular Dystrophy
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Duchenne Muscular Dystrophy
1.2.2 Downstream
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 DUCHENNE MUSCULAR DYSTROPHY MARKET BY TYPE
3.1 By Type
3.1.1 Deflazacort
Table Major Company List of Deflazacort
3.1.2 Prednisone
Table Major Company List of Prednisone
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 PTC Therapeutics (Company Profile, Sales Data etc.)
4.1.1 PTC Therapeutics Profile
Table PTC Therapeutics Overview List
4.1.2 PTC Therapeutics Products & Services
4.1.3 PTC Therapeutics Business Operation Conditions
Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
4.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
4.2.2 Sarepta Therapeutics Products & Services
4.2.3 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.3.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.3.2 Bristol-Myers Squibb Products & Services
4.3.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 ITALFARMACO (Company Profile, Sales Data etc.)
4.4.1 ITALFARMACO Profile
Table ITALFARMACO Overview List
4.4.2 ITALFARMACO Products & Services
4.4.3 ITALFARMACO Business Operation Conditions
Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 BioMarin (Company Profile, Sales Data etc.)
4.5.1 BioMarin Profile
Table BioMarin Overview List
4.5.2 BioMarin Products & Services
4.5.3 BioMarin Business Operation Conditions
Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.6.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.6.2 Daiichi Sankyo Products & Services
4.6.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Solid Biosciences (Company Profile, Sales Data etc.)
4.7.1 Solid Biosciences Profile
Table Solid Biosciences Overview List
4.7.2 Solid Biosciences Products & Services
4.7.3 Solid Biosciences Business Operation Conditions
Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Summit Therapeutics (Company Profile, Sales Data etc.)
4.8.1 Summit Therapeutics Profile
Table Summit Therapeutics Overview List
4.8.2 Summit Therapeutics Products & Services
4.8.3 Summit Therapeutics Business Operation Conditions
Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 FibroGen (Company Profile, Sales Data etc.)
4.9.1 FibroGen Profile
Table FibroGen Overview List
4.9.2 FibroGen Products & Services
4.9.3 FibroGen Business Operation Conditions
Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 NS Pharma (Company Profile, Sales Data etc.)
4.10.1 NS Pharma Profile
Table NS Pharma Overview List
4.10.2 NS Pharma Products & Services
4.10.3 NS Pharma Business Operation Conditions
Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Pfizer (Company Profile, Sales Data etc.)
4.11.1 Pfizer Profile
Table Pfizer Overview List
4.11.2 Pfizer Products & Services
4.11.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 ReveraGen BioPharma (Company Profile, Sales Data etc.)
4.12.1 ReveraGen BioPharma Profile
Table ReveraGen BioPharma Overview List
4.12.2 ReveraGen BioPharma Products & Services
4.12.3 ReveraGen BioPharma Business Operation Conditions
Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
4.13 Wave Life (Company Profile, Sales Data etc.)
4.13.1 Wave Life Profile
Table Wave Life Overview List
4.13.2 Wave Life Products & Services
4.13.3 Wave Life Business Operation Conditions
Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Genethon (Company Profile, Sales Data etc.)
4.14.1 Genethon Profile
Table Genethon Overview List
4.14.2 Genethon Products & Services
4.14.3 Genethon Business Operation Conditions
Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
4.15 Santhera Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Overview List
4.15.2 Santhera Pharmaceuticals Products & Services
4.15.3 Santhera Pharmaceuticals Business Operation Conditions
Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Male
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
6.1.2 Demand in Female
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Duchenne Muscular Dystrophy
2. Table Application Segment of Duchenne Muscular Dystrophy
3. Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Prednisone
5. Table Major Company List of Others
6. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
7. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
8. Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume
10. Table PTC Therapeutics Overview List
11. Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Sarepta Therapeutics Overview List
13. Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Bristol-Myers Squibb Overview List
15. Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table ITALFARMACO Overview List
17. Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table BioMarin Overview List
19. Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Daiichi Sankyo Overview List
21. Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Solid Biosciences Overview List
23. Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Summit Therapeutics Overview List
25. Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table FibroGen Overview List
27. Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table NS Pharma Overview List
29. Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Pfizer Overview List
31. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table ReveraGen BioPharma Overview List
33. Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
34. Table Wave Life Overview List
35. Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Genethon Overview List
37. Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
38. Table Santhera Pharmaceuticals Overview List
39. Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
40. Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
41. Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
42. Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
43. Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
44. Table Regional Demand Comparison List
45. Table Major Application in Different Regions
46. Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
47. Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
48. Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
49. Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume
50. Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
51. Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume
52. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
53. Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
54. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
55. Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume
56. Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
57. Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
58. Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
59. Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
60. Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
61. Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
62. Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
63. Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
64. Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
65. Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
66. Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
67. Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume
68. Table Price Factors List
1. Table Upstream Segment of Duchenne Muscular Dystrophy
2. Table Application Segment of Duchenne Muscular Dystrophy
3. Table Global Duchenne Muscular Dystrophy Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Prednisone
5. Table Major Company List of Others
6. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in USD Million
7. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Type, in Volume
8. Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Type, in Volume
10. Table PTC Therapeutics Overview List
11. Table Business Operation of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Sarepta Therapeutics Overview List
13. Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Bristol-Myers Squibb Overview List
15. Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table ITALFARMACO Overview List
17. Table Business Operation of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table BioMarin Overview List
19. Table Business Operation of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Daiichi Sankyo Overview List
21. Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Solid Biosciences Overview List
23. Table Business Operation of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Summit Therapeutics Overview List
25. Table Business Operation of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table FibroGen Overview List
27. Table Business Operation of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table NS Pharma Overview List
29. Table Business Operation of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Pfizer Overview List
31. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table ReveraGen BioPharma Overview List
33. Table Business Operation of ReveraGen BioPharma (Sales Revenue, Cost, Gross Margin)
34. Table Wave Life Overview List
35. Table Business Operation of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Genethon Overview List
37. Table Business Operation of Genethon (Sales Revenue, Cost, Gross Margin)
38. Table Santhera Pharmaceuticals Overview List
39. Table Business Operation of Santhera Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
40. Table Global Duchenne Muscular Dystrophy Sales Revenue 2016-2020, by Company, in USD Million
41. Table Global Duchenne Muscular Dystrophy Sales Revenue Share 2016-2020, by Company, in USD Million
42. Table Global Duchenne Muscular Dystrophy Sales Volume 2016-2020, by Company, in Volume
43. Table Global Duchenne Muscular Dystrophy Sales Volume Share 2016-2020, by Company, in Volume
44. Table Regional Demand Comparison List
45. Table Major Application in Different Regions
46. Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in USD Million
47. Table Duchenne Muscular Dystrophy Demand Forecast 2021-2026, by Application, in Volume
48. Table Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in Volume
49. Table Duchenne Muscular Dystrophy Market Share in 2026, by Application, in Volume
50. Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in USD Million
51. Table Duchenne Muscular Dystrophy Production 2016-2020, by Region, in Volume
52. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in USD Million
53. Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in USD Million
54. Table Global Duchenne Muscular Dystrophy Market 2016-2020, by Region, in Volume
55. Table Global Duchenne Muscular Dystrophy Market Share 2016-2020, by Region, in Volume
56. Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
57. Table North America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
58. Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
59. Table Europe Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
60. Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
61. Table Asia-Pacific Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
62. Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
63. Table South America Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
64. Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in USD Million
65. Table Middle East & Africa Duchenne Muscular Dystrophy Market Size 2016-2020, by Country, in Volume
66. Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in USD Million
67. Table Duchenne Muscular Dystrophy Market Forecast 2021-2026, by Region, in Volume
68. Table Price Factors List
LIST OF FIGURES
1. Figure Duchenne Muscular Dystrophy Industry Chain Structure
2. Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume
4. Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
7. Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
8. Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
9. Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
10. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020
11. Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
12. Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
13. Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
14. Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume
15. Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
16. Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
17. Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
18. Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
19. Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
23. Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
24. Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview
1. Figure Duchenne Muscular Dystrophy Industry Chain Structure
2. Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Duchenne Muscular Dystrophy Market Growth 2016-2020, by Type, in Volume
4. Figure Global Duchenne Muscular Dystrophy Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Duchenne Muscular Dystrophy Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Duchenne Muscular Dystrophy Market Concentration, in 2020
7. Figure Europe Duchenne Muscular Dystrophy Market Market Concentration, in 2020
8. Figure Asia-Pacific Duchenne Muscular Dystrophy MMarket Concentration, in 2020
9. Figure South America Duchenne Muscular Dystrophy Market Concentration, in 2020
10. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Concentration, in 2020
11. Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in USD Million
12. Figure Duchenne Muscular Dystrophy Demand in Male, 2016-2020, in Volume
13. Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in USD Million
14. Figure Duchenne Muscular Dystrophy Demand in Female, 2016-2020, in Volume
15. Figure Duchenne Muscular Dystrophy Market Growth 2021-2026, by Application, in USD Million
16. Figure Duchenne Muscular Dystrophy Market Share in 2026, by Application, in USD Million
17. Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
18. Figure North America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
19. Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
23. Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
24. Figure South America Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Duchenne Muscular Dystrophy Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview
